Evidence map›Paper›PMID 28422316›Full record

ReviewClinical and experimental immunology2017

Regulatory T cells: tolerance induction in solid organ transplantation.

T Vaikunthanathan, N Safinia, D Boardman, R I Lechler, G Lombardi

Abstract readReview
In one paragraph

Review in Clinical and experimental immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. CD25Frontiers in immunology · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. In vivo Treg expansion under costimulation blockade targets early rejection and improves long-term outcome.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021
    Article
  15. Review
  16. Review
  17. Expansion of CD45RAClinical & translational immunology · 2021
    Article
  18. Article
  19. Review
  20. Immunotherapy for Parkinson's disease.Neurobiology of disease · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

T VaikunthanathanMRC Centre for Transplantation, Division of Transplantation Immunology and Mucosal Biology, King's College London, London, UK.
N SafiniaMRC Centre for Transplantation, Division of Transplantation Immunology and Mucosal Biology, King's College London, London, UK.ORCID 0000-0002-8885-1082
D BoardmanMRC Centre for Transplantation, Division of Transplantation Immunology and Mucosal Biology, King's College London, London, UK.
R I LechlerMRC Centre for Transplantation, Division of Transplantation Immunology and Mucosal Biology, King's College London, London, UK.
G LombardiMRC Centre for Transplantation, Division of Transplantation Immunology and Mucosal Biology, King's College London, London, UK.

Funding

British Heart Foundation RG/13/12/30395Medical Research Council G1002000Medical Research Council MC_PC_14105Medical Research Council MR/J006742/1Medical Research Council MR/L022699/1
6 · The paper itself

Abstract

The concept of regulatory T cell (T

Indexed as

Adaptive ImmunityOrgan TransplantationTransplantation ToleranceAnimalsClinical Trials as TopicCryopreservationGraft RejectionHumansImmunosuppressive AgentsImmunotherapyMiceT-Lymphocytes, RegulatoryImmunosuppressive Agentscell therapyclinical trialsimmunotherapyregulatory T cellstolerancetransplantation

Identifiers

PMID28422316
PMCPMC5508315

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.